OUR ACTIVITIES AND INITIATIVES
Isabelle, a Parisian woman with diabetes, runs on a regular basis, a sport she can now practice thanks to proper use of insulin.
TOUJEO®: A NEW GENERATION OF BASAL INSULIN
Persistent hyperglycemia can, over time, cause serious long-term complications and reduce life expectancy. This risk is something people with diabetes live with every day. Basal insulin is a key treatment for diabetes, which now helps millions of people worldwide reach and maintain their blood glucose targets.
Toujeo® (insulin glargine, 300 units per ml) is a new generation of basal insulin for the treatment of diabetes in adult patients; it is available in 30 countries, with 15 more launches planned around the world before the end of 2016. Patients also have the opportunity to take advantage of a personalized, tailored support to manage their diabetes with the Toujeo® Coach program, developed to support patients and help them better comply with their physician’s instructions.